XML 136 R24.htm IDEA: XBRL DOCUMENT

Share-based Compensation

12 Months Ended

Sep. 30, 2013

17.	Share-based Compensation

	(i) Options

	The Company grants share options to officers and employees and restricted shares of common stock to its non-employee directors as rewards for their services.

	Stock Option Plan

	In May 2005, the Board of Directors adopted the China BAK Battery, Inc. 2005 Stock Option Plan (the “Plan”). The Plan originally authorized the issuance of up to 800,000 shares of the Company's common stock, pursuant to stock options granted under the Plan, or as grants of restricted stock. The exercise price of options granted pursuant to the Plan must be at least equal to the fair market value of the Company's common stock at the date of the grant. Fair market value is determined at the discretion of the designated committee on the basis of reported sales prices for the Company's common stock over a ten-business-day period ending on the grant date. The Plan will terminate on May 16, 2055. On July 28, 2008, the Company's stockholders approved certain amendments to the Plan, including an amendment increasing the total number of shares available for issuance under the Plan to 1,600,000.

Pursuant to the Plan, the Company granted options to purchase 400,000 shares of common stock with an exercise price of $31.25 per share and a contractual life of 6 years on May 16, 2005. In accordance with the vesting provisions of the grants, the options became vested and exercisable under the following schedule:

	Percentage of Initial Options
Number of Shares	Issued	Vesting Date
160,000	40%	July 1, 2007
120,000	30%	January 1, 2008
120,000	30%	July 1, 2008
400,000	100%

Subsequent to the grant date, options to purchase 40,000 shares of common stock were forfeited because the optionees terminated their employment with the Company. In addition, on September 28, 2006, options to purchase a total of 280,000 shares of common stock were cancelled pursuant to the Termination and Release Agreements signed on that day. The remaining options to purchase 80,000 shares of common stock expired on May 15, 2011.

Pursuant to the Plan, the Company also granted options to purchase 300,300 shares of the Company's common stock with a weighted-average exercise price of $16.34 per share on June 25, 2007. In accordance with the vesting provisions of the grants, the options will become vested and exercisable during the period from March 31, 2007 to February 9, 2012 according to each employee's respective agreement.

A summary of share option plan activity for these options during the year ended September 30, 2013 is presented below:

				Weighted	Weighted
				average	average	Aggregate
	Number of			exercise	remaining	intrinsic
	shares			price per share	contractual term	value
Outstanding as of October 1, 2012	121,000		$	16.34	0.6 year
Exercised	-			-
Forfeited/ expired	(121,000	)		16.34
Cancelled	-			-	-
Outstanding as of September 30, 2013	-		$	-
Exercisable as of September 30, 2013	-		$	-

The weighted-average grant-date fair value of options granted during 2007 was $10.75 per share. Non-cash share-based compensation expense has been fully recorded as of September 30, 2011. No non-cash share-based compensation expense was recorded for the years ended September 30, 2013 and 2012.

The fair value of the above option awards granted on June 25, 2007 was estimated on the date of grant using the Black-Scholes Option Valuation Model that uses the following assumptions:

Expected volatility	69.44%
Expected dividends	nil
Expected life	4 – 10 years
Risk-free interest rate	5.09%

	Pursuant to the Plan, the Company also granted options to purchase 72,000 shares of common stock with an exercise price of $21.5 per share with a contractual life of 5 years on January 28, 2008. In accordance with the vesting provisions of the grants, the options will become vested and exercisable during the period from April 28, 2008 to January 28, 2011 according to each employee's respective agreement.

	A summary of share option plan activity for these options during the year ended September 30, 2013 is presented below:

				Weighted		Weighted
				average		average	Aggregate
	Number of			exercise		remaining	intrinsic
	shares			price per share		contractual term	value

Outstanding as of October 1, 2012	72,000		$	21.50		0.1 year
Exercised	-			-
Forfeited/ expired	(72,000	)		(21.50	)
Cancelled	-			-
Outstanding as of September 30, 2013	-		$	-
Exercisable as of September 30, 2013	-		$	-

The weighted average grant-date fair value of options granted on January 28, 2008 was $17.95 per share. No non-cash share-based compensation expense was recorded for the years ended September 30, 2012 and 2013.

The fair value of the above option awards granted on January 28, 2008 was estimated on the date of grant using the Black-Scholes Option Valuation Model that uses the following assumptions.

Expected volatility	120.23%
Expected dividends	nil
Expected life	5 years
Risk-free interest rate	3.59%

On May 29, 2008, the Compensation Committee of the Company's Board of Directors recommended and approved the grant of options to purchase 216,000 shares of the Company's common stock to Mr. Xiangqian Li and options to purchase 34,000 shares to five other employees, with an exercise price of $20.9 per share and a contractual life of 5 years. In accordance with the vesting provisions of the grants, the options will become vested and exercisable during the period from September 30, 2008 to May 28, 2013 according to each employee's respective agreement.

A summary of share option plan activity for these options during the year ended September 30, 2013 is presented below:

						Weighted
				Weighted		average
				average		remaining	Aggregate
	Number of			exercise price		contractual	intrinsic
	shares			per share		term	value

Outstanding as of October 1, 2012	250,000		$	20.90		0.6 year
Exercised	-			-
Forfeited/ expired	(250,000	)		(20.90	)
Cancelled	-			-
Outstanding as of September 30, 2013	-		$	-

Exercisable as of September 30, 2013	-		$	-


	The weighted average grant-date fair value of options granted on May 29, 2008 was $11.80 per share. The Company recorded non-cash share-based compensation expense of $16,525 and $nil for the years ended September 30, 2012 and 2013 respectively, in respect of share options granted on May 29, 2008, which was allocated to general and administrative expenses and research and development expenses.

	The fair value of the above option awards granted on May 29, 2008 was estimated on the date of grant using the Black-Scholes Option Valuation Model that uses the following assumptions.

Expected volatility	59.48%
Expected dividends	nil
Expected life	5 years
Risk-free interest rate	4.01%

On June 22, 2009, the Compensation Committee of the Company's Board of Directors recommended and approved the grant of options to purchase 385,640 shares of the Company's common stock to certain key employees, officers and consultants with an exercise price of $14.05 per share and a contractual life of 7 years. In accordance with the vesting provisions of the grants, the options will become vested and exercisable over five years in twenty equal quarterly installments on the first day of each fiscal quarter beginning on October 1, 2009.

A summary of share option plan activity for these options during the year ended September 30, 2013 is presented below:

					Weighted
				Weighted	average
				average	remaining		Aggregate
	Number of			exercise price	contractual		intrinsic
	shares			per share	term		value ⁽¹⁾

Outstanding as of October 1, 2012	328,671		$	14.05	3.7 years
Exercised	-			-
Forfeited	-			-
Cancelled	(192,111	)		14.05
Outstanding as of September 30, 2013	136,560		$	14.05	2.7 years	$	-
Exercisable as of September 30, 2013	109,248		$	14.05	2.7 years	$	-

⁽¹⁾

The intrinsic values of option at September 30, 2013 was zero since the per share market values of common stock of $2.32, was lower than the exercise price of the option of $14.05 per share.

The weighted average grant-date fair value of options granted on June 22, 2009 was $12.30 per share. The Company recorded non-cash share-based compensation expense of $516,854 and of $259,207 for the years ended September 30, 2012 and 2013 respectively, respectively.

The fair value of the above option awards granted on June 22, 2009 was estimated on the date of grant using the Black-Scholes Option Valuation Model that uses the following assumptions.

Expected volatility	111.03%
Expected dividends	nil
Expected life	7 years
Risk-free interest rate	3.69%

As of September 30, 2013, there were unrecognized compensation costs of $65,148 related to the above non-vested share options. These costs are expected to be recognized over a weighted average period of 1 year.

	On April 8, 2010, the Compensation Committee of the Company's Board of Directors recommended and approved the grant of options to purchase 20,000 shares of the Company's common stock to certain key management with an exercise price of $12.15 per share and a contractual life of 7.5 years. In accordance with the vesting provisions of the grants, the options will become vested and exercisable in eight equal installments beginning on each quarter after September 30, 2010.

	A summary of share option plan activity for these options during the year ended September 30, 2013 is presented below:

			Weighted	Weighted
			average	average		Aggregate
	Number of		exercise	remaining		intrinsic
	shares		price per share	contractual term		value ⁽¹⁾
Outstanding as of October 1, 2012	20,000	$	12.15	5.0 years
Exercised	-		-
Forfeited	-		-
Cancelled	-		-
Outstanding as of September 30, 2013	20,000	$	12.15	4.0 years	$	-
Exercisable as of September 30, 2013	20,000	$	12.15	4.0 years	$	-

⁽¹⁾

The intrinsic values of option at September 30, 2013 was zero since the per share market values of common stock of $2.32, was lower than the exercise price of the option of $12.15 per share.

The weighted average grant-date fair value of options granted on April 8, 2010 was $7.05 per share. The Company recorded non-cash share-based compensation expense of $35,445 and $8,703 for the years ended September 30, 2012 and 2013, respectively, in respect of share options granted on April 8, 2010 which was allocated to research and development expense.

The fair value of the above option awards granted on April 8, 2010 was estimated on the date of grant using the Black-Scholes Option Valuation Model that uses the following assumptions.

	Expected volatility	51.79%
	Expected dividends	nil
	Expected life	7.5 years
	Risk-free interest rate	3.90%

As of September 30, 2013, there were no unrecognized compensation costs related to the above non-vested share options.

(ii) Restricted Shares

Pursuant to the Plan and in accordance with the China BAK Battery, Inc. Compensation Plan for Non-Employee Directors, the Compensation Committee of the Company's Board of Directors recommended and approved the grant of 100,000 restricted shares to the Chief Executive Officer, Mr. Xiangqian Li with a fair value of $14.05 per share on June 22, 2009. In accordance with the vesting schedule of the grant, the restricted shares will vest in twenty equal quarterly installments on the first day of each fiscal quarter beginning on October 1, 2009.

The Company recorded non-cash share-based compensation expense of $175,524 and $91,096 for the years ended September 30, 2012 and 2013, in respect of the restricted shares granted on June 22, 2009, which was allocated to general and administrative expenses.

As of September 30, 2013, there was unrecognized stock-based compensation costs of $23,600 associated with these restricted shares granted to Mr. Xiangqian Li. These costs are expected to be recognized over a weighted-average period of 1 year.

As the Company itself is an investment holding company which is not expected to generate operating profits to realize the tax benefits arising from its net operating loss carried forward, no income tax benefits were recognized for such stock-based compensation cost under stock option plan for the years ended September 30, 2012 and 2013.